CLINICAL ROLE -
OTC Pearl of the Day: Glucosamine Chondroitin
Oral use of glucosamine hydrochloride may reduce pain related to rheumatoid arthritis.
Read More
Daily Medication Pearl: Semaglutide (Rybelsus) for Type 2 Diabetes
Semaglutide (Rybelsus) is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Pharmacy Clinical Pearl of the Day: Atrial Fibrillation
During atrial fibrillation, both of the heart's upper chambers beat chaotically and irregularly without coordination.
Pharmacy Quiz: Test Your Knowledge on Obstructive Sleep Apnea
Ten quiz questions to assess your knowledge on common symptoms and treatments for obstructive sleep apnea.
Daily Medication Pearl: Amisulpride (Barhemsys) for Postoperative Nausea and Vomiting
Amisulpride is a selective dopamine-2 and -3 receptor antagonist that inhibits postoperative nausea and vomiting.
Pharmacy Clinical Pearl of the Day: Signs and Symptoms of Bipolar Disorder
There are several types of bipolar disorders, including mania or hypomania and depression.
Daily Medication Pearl: Vascepa (Icosapent Ethyl) for Cardiovascular Disease
Vascepa is indicated to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients.
Pharmacy Clinical Pearl of the Day: Symptoms of Alzheimer Disease
Approximately 5.8 million people in the United States 65 years of age and older live with Alzheimer disease.
Daily Medication Pearl: Biktarvy for HIV
Because Biktarvy is a complete regimen, coadministration with other antiretroviral medications for the treatment of HIV-1 infection is not recommended.
Pharmacy Clinical Pearl of the Day: Crohn Disease vs Ulcerative Colitis
Ulcerative colitis and Crohn disease are the two main forms of inflammatory bowel disease.
Daily Medication Pearl: Ribociclib (Kisqali) for Breast Cancer
Ribociclib is an inhibitor of cyclin-dependent kinase 4 and 6 and causes tumor growth inhibition.
Pharmacy Clinical Pearl of the Day: Menopause
Menopause can happen in your 40s or 50s, but the average age is 51 years in the United States.
Pharmacy Quiz: Test Your Knowledge on Genital Herpes
Ten quiz questions to assess your knowledge on common symptoms and treatments for genital herpes.
Daily Medication Pearl: Crizanlizumab (Adakveo) for Sickle Cell Disease
Crizanlizumab is a humanized IgG2 kappa monoclonal antibody that binds to P-selectin and blocks interactions with its ligands.
Pharmacy Clinical Pearl of the Day: Amyotrophic Lateral Sclerosis
ALS results in muscles that are reduced in size (atrophic), weak, and soft, or muscles that are stiff, tight, and spastic.
Pharmacist Medication Insights: Cuvitru for Primary Immunodeficiency
Immune globulin subcutaneous (human), 20% solution (Cuvitru) is approved for primary immunodeficiency in patients 2 years of age and older.
Daily Medication Pearl: Vericiguat for Heart Failure
Verquvo is a soluble guanylate cyclase stimulator indicated to reduce the risk of cardiovascular death and heart failure.
Pharmacy Clinical Pearl of the Day: Allergy Types
An overview of the four main types of allergies.
Daily Medication Pearl: Zegalogue (Dasiglucagon) for Severe Hypoglycemia
Dasiglucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver.
Pharmacy Clinical Pearl of the Day: Celiac Disease
For patients with celiac disease, eating gluten triggers an immune response in the small intestine.
Pharmacist Medication Insights: Vibegron for Overactive Bladder
Gemtesa (vibegron; Urovant Sciences) tablets are approved to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Pharmacy Clinical Pearl of the Day: Controlled Substances Schedules
Schedule I drugs, substances, or chemicals are defined as medications with no currently accepted medical use and a high potential for abuse.
Pharmacy Clinical Pearl of the Day: Migraine Types
Migraine headaches can be caused by triggers such as hormonal changes, drinks, stress, sensory stimuli, sleep changes, physical factors, weather changes, medications, foods, and food additives.
Pharmacy Clinical Pearl of the Day: Multiple Sclerosis
In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers, causing deterioration of the nerves.
Pharmacist Medication Insights: Cabozantinib for Renal Cell Carcinoma
Cabozantinib (Cabometyx) was approved in 2016 for patients who have advanced renal cell carcinoma and who received prior anti-angiogenic therapy.
Pharmacy Clinical Pearl of the Day: Obstructive Sleep Apnea
There are several types of sleep apnea, but the most common is obstructive sleep apnea.
Pharmacy Quiz: Test Your Knowledge on C. Difficile Infection
Ten quiz questions to assess your knowledge on common symptoms and treatments for Clostridioides difficile.
Pharmacy Clinical Pearl of the Day: Head Lice
Treatment options for head live include Permethrin (Nix) and Pyrethrin (Rid) as OTC options and prescription medicines such as Ivermectin (Sklice), Spinosad (Natroba), and Malathion.
Pharmacy Clinical Pearl of the Day: Crohn Disease
Crohn disease causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Pharmacist Medication Insights: Dupilumab for Atopic Dermatitis
Dupilumab (Dupixent) was approved in 2017 for the treatment of adults with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies.